Perthera
Perthera offers an AI-powered precision oncology platform that analyzes multi-omic data and patient history to predict optimal treatment options and accelerate therapeutic innovation. Their flagship product, the Perthera Report®, provides oncologists with ranked therapy options, backed by real-world evidence and clinical proof of a 2.4x improvement in progression-free survival. The platform also supports biopharma companies by accelerating R&D through access to their AI-enhanced Real World Evidence (RWE) data pipeline, matching patients to clinical trials. Perthera aims to make precision oncology the standard of care, optimizing physician resources and shortening time to decision for cancer patients.
Perthera
Perthera offers an AI-powered precision oncology platform that analyzes multi-omic data and patient history to predict optimal treatment options and accelerate therapeutic innovation. Their flagship product, the Perthera Report®, provides oncologists with ranked therapy options, backed by real-world evidence and clinical proof of a 2.4x improvement in progression-free survival. The platform also supports biopharma companies by accelerating R&D through access to their AI-enhanced Real World Evidence (RWE) data pipeline, matching patients to clinical trials. Perthera aims to make precision oncology the standard of care, optimizing physician resources and shortening time to decision for cancer patients.